SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.

BMJ Open · 2016 · PMC4769433 · PMID 26911584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

All SGLT-2 inhibitors reduced SBP compared with placebo, but this failed to reach statistical significance for dapagliflozin 10 mg, tofogliflozin 10 and 40 mg because of wide CIs ( figure 8 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.